1-4 of 4
Ajibade Ashaye
Close
Sort by
Journal Articles

The Comparative Effectiveness of A+AVD vs PET-guided ABVD for the Management of Patients with Advanced Hodgkin Lymphoma: A Systematic Review and Matching-Adjusted Indirect Treatment Comparison

Fjoralba Kristo, Victoria Federico Paly, Katherine Fazioli, Conor McCloskey, Sunita Nair, Bipin N. Savani, Athanasios Zomas, Ajibade Ashaye
Journal: Blood
Blood (2023) 142 (Supplement 1): 1713.
https://doi.org/10.1182/blood-2023-174845
Published: 2023
Journal Articles

Real-World Treatment Patterns and Patient Outcomes in Relapsed/Refractory Hodgkin Lymphoma in the US

Fjoralba Kristo, Melissa Lingohr-Smith, Jay Lin, Ajibade Ashaye
Journal: Blood
Blood (2023) 142 (Supplement 1): 7347.
https://doi.org/10.1182/blood-2023-174435
Published: 2023
Journal Articles

Minimal Residual Disease-Negative Complete Remission at the End of Induction Is a Prognostic Indicator of Long-Term Survival in Adult Patients with Ph+ Acute Lymphoblastic Leukemia Receiving First-Line Therapy

Ajibade Ashaye, Yves Chalandon, Hervé Dombret, Katherine Fazioli, Bingxia Wang, Ibrahim Aldoss, Fei Huang, Jessica T. Leonard, Nora Szabo, Conor McCloskey, Sunita Nair, Mehul Dalal, Meliessa Hennessy, Tammie Yeh, Talha Badar, Hagop Kantarjian, Josep-Maria Ribera, Elias Jabbour
Journal: Blood
Blood (2023) 142 (Supplement 1): 6075.
https://doi.org/10.1182/blood-2023-179645
Published: 2023
Journal Articles

Comparative Efficacy and Safety of Gemtuzumab Ozogamicin (GO) Plus Daunorubicin-Cytarabine Combination and Comparators As Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia

Ajibade Ashaye, Zarmina S. Khankhel, Yingxin Xu, Kyle Fahrbach, PhD, Ruth Mokgokong, Michelle Orme, Kathryn Lang, Joseph C. Cappelleri, PhD MPH, MS, Carla M. Mamolo
Journal: Blood
Blood (2017) 130 (Supplement 1): 2103.
https://doi.org/10.1182/blood.V130.Suppl_1.2103.2103
Published: 2017